BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 12003183)

  • 21. Protein phosphatase 1 and 2A inhibitors activate acyl-CoA:cholesterol acyltransferase and cholesterol ester formation in isolated rat hepatocytes.
    Hernández ML; Martínez MJ; López de Heredia M; Ochoa B
    Biochim Biophys Acta; 1997 Nov; 1349(3):233-41. PubMed ID: 9434137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein phosphatase inhibitors arrest cell cycle and reduce branching morphogenesis in fetal rat lung cultures.
    Taylor BK; Stoops TD; Everett AD
    Am J Physiol Lung Cell Mol Physiol; 2000 May; 278(5):L1062-70. PubMed ID: 10781439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
    Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
    BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploiting protein phosphatase inhibitors based on cantharidin analogues for cancer drug discovery.
    Deng L; Dong J; Wang W
    Mini Rev Med Chem; 2013 Jun; 13(8):1166-76. PubMed ID: 23373656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of the protein phosphatases inhibitor cantharidin on beta-adrenoceptor-mediated vasorelaxation.
    Knapp J; Bokník P; Linck B; Lüss H; Müller FU; Nacke P; Neumann J; Vahlensieck U; Schmitz W
    Br J Pharmacol; 1997 Feb; 120(3):421-8. PubMed ID: 9031745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cantharidin impedes the activity of protein serine/threonine phosphatase in Plutella xylostella.
    Chen X; Liu J; Zhang Y
    Mol Biosyst; 2014 Feb; 10(2):240-50. PubMed ID: 24253262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cantharidin-induced mitotic arrest is associated with the formation of aberrant mitotic spindles and lagging chromosomes resulting, in part, from the suppression of PP2Aalpha.
    Bonness K; Aragon IV; Rutland B; Ofori-Acquah S; Dean NM; Honkanen RE
    Mol Cancer Ther; 2006 Nov; 5(11):2727-36. PubMed ID: 17121919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiosensitization of tumour cells by cantharidin and some analogues.
    Price WA; Stobbe CC; Park SJ; Chapman JD
    Int J Radiat Biol; 2004 Apr; 80(4):269-79. PubMed ID: 15204704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optically active cantharidin analogues possessing selective inhibitory activity on Ser/Thr protein phosphatase 2B (calcineurin): implications for the binding mode.
    Baba Y; Hirukawa N; Sodeoka M
    Bioorg Med Chem; 2005 Sep; 13(17):5164-70. PubMed ID: 15951185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ras mutation, irrespective of cell type and p53 status, determines a cell's destiny to undergo apoptosis by okadaic acid, an inhibitor of protein phosphatase 1 and 2A.
    Rajesh D; Schell K; Verma AK
    Mol Pharmacol; 1999 Sep; 56(3):515-25. PubMed ID: 10462539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein phosphatase 2A inhibition and circumvention of cisplatin cross-resistance by novel TCM-platinum anticancer agents containing demethylcantharidin.
    To KK; Wang X; Yu CW; Ho YP; Au-Yeung SC
    Bioorg Med Chem; 2004 Sep; 12(17):4565-73. PubMed ID: 15358284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein phosphatase in neuroblastoma cells: [3H]cantharidin binding site in relation to cytotoxicity.
    Laidley CW; Cohen E; Casida JE
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1152-8. PubMed ID: 9067298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein phosphatase 2A is involved in hyphal growth of Neurospora crassa.
    Yatzkan E; Szöor B; Fehér Z; Dombrádi V; Yarden O
    Mol Gen Genet; 1998 Sep; 259(5):523-31. PubMed ID: 9790584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cantharidin suppressed breast cancer MDA-MB-231 cell growth and migration by inhibiting MAPK signaling pathway.
    Gu XD; Xu LL; Zhao H; Gu JZ; Xie XH
    Braz J Med Biol Res; 2017 Jul; 50(7):e5920. PubMed ID: 28678918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The natural anticancer agent cantharidin alters GPI-anchored protein sorting by targeting Cdc1-mediated remodeling in endoplasmic reticulum.
    Sahu PK; Tomar RS
    J Biol Chem; 2019 Mar; 294(11):3837-3852. PubMed ID: 30659098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cantharidin induces G2/M arrest and triggers apoptosis in renal cell carcinoma.
    Ren Y; Zhang SW; Xie ZH; Xu XM; Chen LL; Lou ZG; Weng GB; Yao XP
    Mol Med Rep; 2016 Dec; 14(6):5614-5618. PubMed ID: 27878266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular carcinoma cell lines from diethylnitrosamine phenobarbital-treated rats. Characterization and sensitivity to endothall, a protein serine/threonine phosphatase-2A inhibitor.
    Thièry JP; Blazsek I; Legras S; Marion S; Reynes M; Anjo A; Adam R; Misset JL
    Hepatology; 1999 May; 29(5):1406-17. PubMed ID: 10216123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sodium cantharidate induces Apoptosis in breast cancer cells by regulating energy metabolism via the protein phosphatase 5-p53 axis.
    Pang JL; Huang FH; Zhang YH; Wu Y; Ge XM; Li S; Li X
    Toxicol Appl Pharmacol; 2021 Nov; 430():115726. PubMed ID: 34537213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The radiotherapy-sensitization effect of cantharidin: Mechanisms involving cell cycle regulation, enhanced DNA damage, and inhibited DNA damage repair.
    Xu MD; Liu SL; Zheng BB; Wu J; Wu MY; Zhang Y; Gong FR; Tao M; Zhang J; Li W
    Pancreatology; 2018 Oct; 18(7):822-832. PubMed ID: 30201439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A synthetic cantharidin analog for the enhancement of doxorubicin suppression of stem cell-derived aggressive sarcoma.
    Zhang C; Peng Y; Wang F; Tan X; Liu N; Fan S; Wang D; Zhang L; Liu D; Wang T; Wang S; Zhou Y; Su Y; Cheng T; Zhuang Z; Shi C
    Biomaterials; 2010 Dec; 31(36):9535-43. PubMed ID: 20875681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.